A retrospective cohort study reveals that steroid use during acute SARS-CoV-2 infection is not associated with a reduced risk for pediatric long COVID. Treatment with corticosteroids during acute SARS ...
A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...
HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果